Impact of COVID-19 pandemic on the course of refractory chronic spontaneous urticaria under omalizumab treatment.
Olgaç M, Yeğit OO, Beyaz Ş, Öztop N, Tüzer C, Eyice D, Karadağ P, Coşkun R, Demir S, Çolakoğlu B, Büyüköztürk S, Gelincik A.
Olgaç M, et al. Among authors: colakoglu b.
An Bras Dermatol. 2023 Mar-Apr;98(2):189-197. doi: 10.1016/j.abd.2022.08.006. Epub 2022 Dec 14.
An Bras Dermatol. 2023.
PMID: 36609081
Free PMC article.